Trials / Completed
CompletedNCT00330785
Open Label Study Assessing Effectiveness Of Amlodipine/Atorvastatin In Subjects With Hypertension and Dyslipidaemia
An International, Multicentre, Open Label Study To Assess The Effectiveness Of Amlodipine -Atorvastatin Combination In Subjects With Hypertension and Dyslipidaemia. (The JEWEL Study)
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 1,250 (planned)
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc. · Industry
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the effectiveness of amlodipine/atorvastatin therapy by assessing the percentage of subjects who reach target blood pressure (BP) and LDL-C targets as defined by their governing guidelines.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Amlodipine/Atorvastatin |
Timeline
- Start date
- 2004-10-01
- Completion
- 2005-09-01
- First posted
- 2006-05-29
- Last updated
- 2021-01-27
Locations
126 sites across 2 countries: Canada, United Kingdom
Source: ClinicalTrials.gov record NCT00330785. Inclusion in this directory is not an endorsement.